Find a Doctor

Physician Profile

Mark W. Kieran, MD, PhD

Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-4386
Appointment Phone: 617-632-4386
Fax: 617-632-4897
Preferred Contact Method: email

General

Treatment Centers
Disciplines
Neuro-oncologist
Clinical Interests
Neuro-oncology, Experimental therapies, Anti-angiogenesis, Phase I/Phase II trials

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215

Background

Board Certifications
Pediatric Hematology/Oncology, 1996, 2003, 2013
Pediatrics, 1993
Fellowships
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology
Residency
Montreal Children's Hospital, McGill University
Medical School
University of Calgary Faculty of Medicine
Biography

Dr. Kieran received his PhD in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. He completed postgraduate training in molecular biology at the Pasteur Institute in Paris. After a pediatric residency in Montreal at McGill University, he received postdoctoral education at Boston Children’s Hospital (BCH). In 1998, he became director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s. In addition to his role in the treatment of patients with brain tumors and the development of novel agents for the treatment of recurrent tumors, he continues to focus his laboratory efforts on angiogenesis agents from work he started in the laboratory of the late Dr. Judah Folkman.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.